These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7070893)

  • 1. Complications associated with digoxin therapy in low-birth weight infants.
    Johnson GL; Desai NS; Pauly TH; Cunningham MD
    Pediatrics; 1982 Apr; 69(4):463-5. PubMed ID: 7070893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum digoxin levels in neonates whose weights are less than 1,500 grams.
    Patterson MW; Reid G; Sandor GG
    Pediatr Pharmacol (New York); 1982; 2(3):217-21. PubMed ID: 7162876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and echocardiographic effects of digoxin in low birth weight infants with left-to-right shunting due to patent ductus arteriosus.
    Warburton D; Bell EF; Oh W
    Dev Pharmacol Ther; 1980; 1(2-3):189-200. PubMed ID: 6927548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 24-hour serum digoxin level as a prognosticator of dosage requirement in low-birth-weight (LBW) infants.
    Ng PK; Collins-Nakai RL
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):71-9. PubMed ID: 6648043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin therapy in low-birth-weight infants with patent ductus arteriosus.
    Berman W; Dubynsky O; Whitman V; Friedman Z; Maisels MJ
    J Pediatr; 1978 Oct; 93(4):652-5. PubMed ID: 702246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of patent ductus arteriosus and phototherapy in infants weighing less than 1000 grams.
    Barefield ES; Dwyer MD; Cassady G
    J Perinatol; 1993; 13(5):376-80. PubMed ID: 8263622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in serum digoxin concentrations after indomethacin therapy in a full-term neonate.
    Haig GM; Brookfield EG
    Pharmacotherapy; 1992; 12(4):334-6. PubMed ID: 1518732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimum therapy of digoxin for low-birth-weight infants.
    Wettrell G
    Pediatrics; 1982 Dec; 70(6):1010-1. PubMed ID: 7145528
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome of cardiac surgery in low birth weight and premature infants.
    Oppido G; Pace Napoleone C; Formigari R; Gabbieri D; Pacini D; Frascaroli G; Gargiulo G
    Eur J Cardiothorac Surg; 2004 Jul; 26(1):44-53. PubMed ID: 15200978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
    Supapannachart S; Khowsathit P; Patchakapati B
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S87-92. PubMed ID: 10730525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
    Cordero L; Nankervis CA; Delooze D; Giannone PJ
    J Perinatol; 2007 Mar; 27(3):158-63. PubMed ID: 17251986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method.
    Desfrere L; Zohar S; Morville P; Brunhes A; Chevret S; Pons G; Moriette G; Rey E; Treluyer JM
    J Clin Pharm Ther; 2005 Apr; 30(2):121-32. PubMed ID: 15811164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter management of patent ductus arteriosus in sick ventilated small infants.
    Kannan BR; Anil SR; Padhi SS; Kumar RK
    Indian Heart J; 2004; 56(3):232-4. PubMed ID: 15584567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management.
    Neu J; Ariagno RL; Johnson JD; Pitlick PT; Cohen RS; Beets CL; Sunshine P
    Pediatr Pharmacol (New York); 1981; 1(3):245-9. PubMed ID: 7346744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
    Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe retinopathy of prematurity in extremely low birth weight infants after short-term dexamethasone therapy.
    Ramanathan R; Siassi B; deLemos RA
    J Perinatol; 1995; 15(3):178-82; quiz 183-4. PubMed ID: 7666264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.